Event Details
We are pleased to provide details of our next BioTuesday on 25 February, kindly hosted by FTI Consulting in Central London. This edition of our ever-popular knowledge sharing and networking event will be spotlighting:
'The latest R&D in the Metabolic Disease and Obesity Space'
The event will feature presentations from experts across Metabolic Disease and Obesity, including Big Pharma, patient advocacy and R&D SME's including those working with Diagnostics, Medtech and Therapeutics.
๏ปฟOutline Programme:
18.00 โ 18.30 Guest arrivals and networking
18.30 - 18:35 Welcome from OBN and FTI Consulting
18:35 - 20:00 Company presentations from:
- Matthew Coghlan, Vice President - Head Incretin Portfolio Science at Eli Lilly and Company, full details on Lilly's approach to obesity can be found here
- Giorgio Gissey, CEO of Keyron Medical Technology, who provide advanced medical devices for the treatment of metabolic diseases
- Adrien Lemoine, Co-Founder and Chief Executive Officer at Bloomsbury Genetic Therapies, who are developing potentially curative treatments for patients suffering from rare neurological and metabolic diseases
- Jon Reesโ, CEO at MitoRxโ who are developing mitochondrial-targeted therapeutics extending fat loss and preserving muscle in obesity-related indications
- Sarah Le Brocq, UK Head of Public Affairs at Reset Health, who help patients manage obesity and Type 2 diabetes via their Roczen app & Founder of All About Obesity, who support and advocate for those living with obesity
Final speakers to be announced soon...
20.10 โ 20.30 Audience & Presenter Q&A
20.30 โ 21.30 Networking
About our BioTuesday events:
OBN BioTuesday's are monthly knowledge sharing and networking events, designed to showcase the latest research, advancements, treatments and patient impact within a particular therapy area of the life sciences industry. The evening programme features broad industry updates followed by a series of showcase presentations from innovative R&D SME's, across Medtech, Devices, Digital Health and Therapeutics. There is always time available for audience questions as well as networking over drinks.
Attendance is open for all, complimentary tickets available for OBN Members, Research Scientists & PhD Students. A nominal charge applies for all other for non-OBN Members.
For more information, please email events@obn.org.uk.
